Education Library

Amir Kaki, M.D., describes the first results from the Impella ECP Pivotal Study.

Jacob Møller, M.D., and Chuck Simonton, M.D., discuss the DanGer Shock RCT and new data presented at TCT 2024.

A panel of interventional cardiologists discuss the DanGer Shock RCT results and the implications for AMICS patient management.

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS) during high risk intervention, highlighting the following topics...

Babar Basir, D.O., discusses revascularization best practices in patients with cardiogenic shock.

In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.

This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.

Javier Escaned, MD, Nikos Werner, MD, Dirk Westermann, MD, and Vasileios Panoulas, MD, answer questions following the EuroPCR session “How to optimize high-risk patient outcome?”

“The precarious balance between bleeding and thrombosis in patients with p-LVAD support is often the primary reason that patients’ outcomes are jeopardized,” write the authors of this article, which discusses anticoagulation strategies and anticoagulant management in the setting of Protected PCI.

This article describes pre-procedural preparation, with a particular focus on imaging techniques for screening and guiding vascular access in patients undergoing Protected PCI.

Fadi Al-Rashid, MD, discusses his publication on standard pre-procedural clinical workup for Protected PCI.

Prof. Christophe Vandenbriele, MD, urges caution and the need for context when drawing conclusions from retrospective analyses in critically ill patients with cardiogenic shock.

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

Jürgen Leick, MD, discusses his paper on optimizing patient selection in high-risk protected percutaneous coronary intervention.

Prof. Dr. Christophe Vandenbriele discusses his recently published paper on anticoagulation in patients underoing Protected PCI procedures.